{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:50:43Z","timestamp":1791377443812,"version":"4.3.2"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University Joint Funding Project","award":["202201020318"],"award-info":[{"award-number":["202201020318"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Elevated soluble stimulating factor 2 (sST2) level is observed in cardiovascular diseases, such as heart failure and acute coronary syndrome, which reflects myocardial fibrosis and hypertrophy, indicating adverse clinical outcomes. However, the association between sST2 and hypertensive heart disease are less understood. This study aimed to determine the relationship of sST2 with left ventricular hypertrophy (LVH) and geometric remodeling in essential hypertension (EH).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We enrolled 483 patients (aged 18\u201380 years; 51.35% female). sST2 measurements and echocardiographic analyses were performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Stepwise multiple linear regression analysis showed significant associations among sST2, left ventricular (LV) mass, and LV mass index. The prevalence of LVH and concentric hypertrophy (CH) increased with higher sST2 grade levels (P for trend\u2005&amp;lt;\u20050.05). Logistic regression analysis suggested that the highest tertile of sST2 was significantly associated with increased LVH risk, compared with the lowest tertile (multivariate-adjusted odds ratio [OR] of highest group: 6.61; P\u2005&amp;lt;\u20050.001). Similar results were observed in the left ventricular geometric remodeling; the highest tertile of sST2 was significantly associated with increased CH risk (multivariate-adjusted OR of highest group: 5.80; P\u2005&amp;lt;\u20050.001). The receiver operating characteristic analysis results revealed that sST2 had potential predictive value for LVH (area under the curve [AUC]: 0.752, 95% confidence interval [CI]: 0.704\u20130.800) and CH (AUC: 0.750, 95% CI: 0.699\u20130.802) in patients with EH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>High sST2 level is strongly related to LVH and CH in patients with EH and can be used as a biomarker for the diagnosis and risk assessment of hypertensive heart disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CLINICAL TRIALS REGISTRATION<\/jats:title>\n                  <jats:p>Trial Number ChiCTR2400082764<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajh\/hpae105","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T11:03:26Z","timestamp":1723547006000},"page":"987-994","source":"Crossref","is-referenced-by-count":5,"title":["Soluble ST2 Is a Biomarker Associated With Left Ventricular Hypertrophy and Concentric Hypertrophy in Patients With Essential Hypertension"],"prefix":"10.1093","volume":"37","author":[{"given":"Xia","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine , Guangzhou ,","place":["China"]},{"name":"The Second Clinical College, Guangzhou University of Chinese Medicine , Guangzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Jie","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine , Guangzhou ,","place":["China"]},{"name":"The Second Clinical College, Guangzhou University of Chinese Medicine , Guangzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine , Guangzhou ,","place":["China"]},{"name":"The Second Clinical College, Guangzhou University of Chinese Medicine , Guangzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Feng","family":"Xu","sequence":"additional","affiliation":[{"name":"The Second Clinical College, Guangzhou University of Chinese Medicine , Guangzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Cheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine , Guangzhou ,","place":["China"]},{"name":"The Second Clinical College, Guangzhou University of Chinese Medicine , Guangzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Yang","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine , Guangzhou ,","place":["China"]},{"name":"The Second Clinical College, Guangzhou University of Chinese Medicine , Guangzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Ming","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine , Guangzhou ,","place":["China"]},{"name":"The Second Clinical College, Guangzhou University of Chinese Medicine , Guangzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Hui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine , Guangzhou ,","place":["China"]},{"name":"The Second Clinical College, Guangzhou University of Chinese Medicine , Guangzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8996-5172","authenticated-orcid":false,"given":"Chuangchang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine , Guangzhou ,","place":["China"]},{"name":"The Second Clinical College, Guangzhou University of Chinese Medicine , Guangzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"2024111510312367800_CIT0001","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00108-019-0576-9","article-title":"Kommentar zu den Leitlinien (2018) der Europ\u00e4ischen Gesellschaft f\u00fcr Kardiologie (ESC) und der Europ\u00e4ischen Gesellschaft f\u00fcr Hypertonie (ESH) f\u00fcr das Management der arteriellen Hypertonie","volume":"60","author":"Mahfoud","year":"2019","journal-title":"Internist (Berl)"},{"key":"2024111510312367800_CIT0002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.lpm.2018.11.017","article-title":"Hypertension art\u00e9rielle permanente essentielle: d\u00e9finitions et revue h\u00e9modynamique, clinique et th\u00e9rapeutique","volume":"48","author":"Vall\u00e9e","year":"2019","journal-title":"La Presse M\u00e9dicale"},{"key":"2024111510312367800_CIT0003","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.3390\/ijms24043881","article-title":"Left ventricular hypertrophy and ventricular Tachyarrhythmia: the role of biomarkers","volume":"24","author":"Bacharova","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2024111510312367800_CIT0004","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/ehjci\/jeab216","article-title":"Left ventricular and atrial remodelling in hypertensive patients using thresholds from international guidelines and EMINCA data","volume":"23","author":"Sheng","year":"2022","journal-title":"Eur Heart J \u2013 Cardiovasc Imaging"},{"key":"2024111510312367800_CIT0005","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41371-021-00543-2","article-title":"The influence of left ventricular geometry on myocardial work in essential hypertension","volume":"36","author":"Tadic","year":"2022","journal-title":"J Hum Hypertens"},{"key":"2024111510312367800_CIT0006","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/ajh\/hpaa194","article-title":"Echocardiography predictors of survival in hypertensive patients with left ventricular hypertrophy","volume":"34","author":"Guzik","year":"2021","journal-title":"Am J Hypertens"},{"key":"2024111510312367800_CIT0007","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pcad.2019.11.009","article-title":"Left ventricular hypertrophy and hypertension","volume":"63","author":"Yildiz","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"2024111510312367800_CIT0008","first-page":"1146","article-title":"Left-ventricular geometry and risk of sudden cardiac arrest in patients with preserved or moderately reduced left-ventricular ejection fraction","volume":"19","author":"Aro","year":"2017","journal-title":"Europace"},{"key":"2024111510312367800_CIT0009","doi-asserted-by":"crossref","first-page":"e001243","DOI":"10.1136\/openhrt-2020-001243","article-title":"Left ventricular longitudinal shortening: relation to stroke volume and ejection fraction in ageing, blood pressure, body size and gender in the HUNT3 study","volume":"7","author":"St\u00f8ylen","year":"2020","journal-title":"Open Heart"},{"key":"2024111510312367800_CIT0010","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s10554-019-01665-y","article-title":"Age related structural and functional changes in left ventricular performance in healthy subjects: a 2D echocardiographic study","volume":"35","author":"Vriz","year":"2019","journal-title":"Int J Cardiovasc Imaging"},{"key":"2024111510312367800_CIT0011","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/jch.13726","article-title":"Conventional and new electrocardiographic criteria for hypertension-mediated cardiac organ damage: a narrative review","volume":"21","author":"Miceli","year":"2019","journal-title":"J Clin Hypertens"},{"key":"2024111510312367800_CIT0012","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.amjcard.2019.06.003","article-title":"Interrelation between electrocardiographic left atrial abnormality, left ventricular hypertrophy, and mortality in participants with hypertension","volume":"124","author":"Ahmad","year":"2019","journal-title":"Am J Cardiol"},{"key":"2024111510312367800_CIT0013","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jch.14786","article-title":"Nomogram-based risk assessment model for left ventricular hypertrophy in patients with essential hypertension: incorporating clinical characteristics and biomarkers","volume":"26","author":"Wang","year":"2024","journal-title":"J Clin Hypertens"},{"key":"2024111510312367800_CIT0014","doi-asserted-by":"crossref","first-page":"e004152","DOI":"10.1161\/JAHA.116.004152","article-title":"Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic (the Campania Salute Network)","volume":"6","author":"L\u00f8nnebakken","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2024111510312367800_CIT0015","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.1096\/fj.201801563R","article-title":"Cardiotrophin-1 is an anti-inflammatory cytokine and promotes IL-4\u2013induced M2 macrophage polarization","volume":"33","author":"Carneros","year":"2019","journal-title":"FASEB J"},{"key":"2024111510312367800_CIT0016","doi-asserted-by":"crossref","first-page":"780641","DOI":"10.3389\/fimmu.2021.780641","article-title":"Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a biomarker of systemic chronic inflammation","volume":"12","author":"Rasmussen","year":"2021","journal-title":"Front Immunol"},{"key":"2024111510312367800_CIT0017","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3389\/fphys.2020.00661","article-title":"Biology of Tissue Inhibitor of Metalloproteinase 3 (TIMP3), and its therapeutic implications in cardiovascular pathology","volume":"11","author":"Fan","year":"2020","journal-title":"Front Physiol"},{"key":"2024111510312367800_CIT0018","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.recesp.2023.02.010","article-title":"Circulating ST2, from biomarker to pathogenic mediator","volume":"76","author":"Pascual-Figal","year":"2023","journal-title":"Rev Esp Cardiol"},{"key":"2024111510312367800_CIT0019","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/ehf2.13203","article-title":"Circulating multimarker approach to identify patients with preclinical left ventricular remodelling and\/or diastolic dysfunction","volume":"8","author":"Huttin","year":"2021","journal-title":"ESC Heart Failure"},{"key":"2024111510312367800_CIT0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ehf2.14147","article-title":"Expression of soluble ST2 in patients with essential hypertension and its relationship with left ventricular hypertrophy","volume":"10","author":"Wei","year":"2023","journal-title":"ESC Heart Failure"},{"key":"2024111510312367800_CIT0021","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ajh.2008.16","article-title":"Left ventricular hypertrophy and clinical outcomes in hypertensive patients","volume":"21","author":"Ruilope","year":"2008","journal-title":"Am J Hypertens"},{"key":"2024111510312367800_CIT0022","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/HJH.0000000000003003","article-title":"A nomogram integrating non-ECG factors with ECG to screen left ventricular hypertrophy among hypertensive patients from northern China","volume":"40","author":"Li","year":"2022","journal-title":"J Hypertens"},{"key":"2024111510312367800_CIT0023","doi-asserted-by":"crossref","first-page":"e12728","DOI":"10.1111\/anec.12728","article-title":"Diagnostic performance of electrocardiographic criteria in echocardiographic diagnosis of different patterns of left ventricular hypertrophy","volume":"25","author":"Oikonomou","year":"2020","journal-title":"Noninvasive Electrocardiol"},{"key":"2024111510312367800_CIT0024","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41371-021-00570-z","article-title":"Hypertension in China: burdens, guidelines and policy responses: a state-of-the-art review","volume":"36","author":"Yin","year":"2022","journal-title":"J Hum Hypertens"},{"key":"2024111510312367800_CIT0025","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/jch.13919","article-title":"Modified Cornell electrocardiographic criteria in the assessment of left ventricular hypertrophy geometry of patients with essential hypertension","volume":"22","author":"Xu","year":"2020","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2024111510312367800_CIT0026","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/ajh\/hpaa083","article-title":"Performance of electrocardiographic criteria for echocardiographically diagnosed left ventricular hypertrophy in Chinese hypertensive patients","volume":"33","author":"Wang","year":"2020","journal-title":"Am J Hypertens"},{"key":"2024111510312367800_CIT0027","first-page":"e26376","article-title":"Evaluation of different criteria in the diagnosis of left ventricular hypertrophy by electrocardiogram in comparison with echocardiogram","volume":"14","author":"Marcato","year":"2022","journal-title":"Cureus"},{"key":"2024111510312367800_CIT0028","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"2024111510312367800_CIT0029","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.3390\/jcm12093136","article-title":"sST2 and heart failure\u2014clinical utility and prognosis","volume":"12","author":"Dudek","year":"2023","journal-title":"J Clin Med"},{"key":"2024111510312367800_CIT0030","doi-asserted-by":"crossref","first-page":"e1054","DOI":"10.1161\/CIR.0000000000000490","article-title":"Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association","volume":"135","author":"Chow","year":"2017","journal-title":"Circulation"},{"key":"2024111510312367800_CIT0031","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/jhh.2013.130","article-title":"The effect of left ventricular remodelling on soluble ST2 in a cohort of hypertensive subjects","volume":"28","author":"Ojji","year":"2014","journal-title":"J Hum Hypertens"},{"key":"2024111510312367800_CIT0032","first-page":"870","article-title":"The natural history of left ventricular geometry in the community","volume":"7","author":"Lieb","year":"2014","journal-title":"JACC: Cardiovasc Imaging."},{"key":"2024111510312367800_CIT0033","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000508402","article-title":"Relationship between soluble ST2 and left ventricular geometry in maintenance hemodialysis patients","volume":"50","author":"Zhang","year":"2021","journal-title":"Blood Purif"},{"key":"2024111510312367800_CIT0034","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/jch.12205","article-title":"Relationship between left ventricular geometry and soluble ST 2 in a cohort of hypertensive patients","volume":"15","author":"Ojji","year":"2013","journal-title":"J Clin Hypertens"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/advance-article-pdf\/doi\/10.1093\/ajh\/hpae105\/59022821\/hpae105.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/37\/12\/987\/60409432\/hpae105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/37\/12\/987\/60409432\/hpae105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T10:31:42Z","timestamp":1731666702000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/37\/12\/987\/7732327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":34,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,8,13]]},"published-print":{"date-parts":[[2024,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpae105","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,8,13]]}}}